RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis-Reference-Cited by-同舟云学术

RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis

Published:2018-02 Issue:2 Volume:33 Page:259-273.e7
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Cortes Jose R.,Ambesi-Impiombato Alberto,Couronné Lucile,Quinn S. Aidan,Kim Christine S.,da Silva Almeida Ana C.,West Zachary,Belver Laura,Martin Marta Sanchez,Scourzic Laurianne,Bhagat Govind,Bernard Olivier A.,Ferrando Adolfo A.,Palomero Teresa

Funder

National Cancer Institute

Leukemia & Lymphoma Society

Institut National Du Cancer

LNCC

ITMO

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference52 articles.

1. Generation of CD4CreER(T(2)) transgenic mice to study development of peripheral CD4-T cells;Aghajani;Genesis,2012

2. Characterization of human inducible costimulator ligand expression and function;Aicher;J. Immunol.,2000

3. Rho regulates T cell receptor ITAM-induced lymphocyte spreading in an integrin-independent manner;Borroto;Eur. J. Immunol.,2000

4. Off the beaten paths: alternative and crosstalk regulation of Rho GTPases;Boulter;FASEB J.,2012

5. ICOS controls the pool size of effector-memory and regulatory T cells;Burmeister;J. Immunol.,2008

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo CAR T cell therapy against angioimmunoblastic T cell lymphoma;Journal of Experimental & Clinical Cancer Research;2024-09-14

2. Peripheral T-cell lymphoma: From biology to practice to the future;Cancer Treatment Reviews;2024-09

3. Phase 2 trial of the farnesyltransferase inhibitor tipifarnib for relapsed/refractory peripheral T-cell lymphoma;Blood Advances;2024-08-30

4. Predicting the efficiency of chidamide in patients with angioimmunoblastic T-cell lymphoma using machine learning algorithm;Frontiers in Pharmacology;2024-08-28

5. Mutations in Ras homolog family member A in patients with peripheral T-cell lymphoma and implications for personalized medicine;Cancer Biology & Medicine;2024-08-09